Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Qiufan Zheng"'
Autor:
Dongshao Chen, Fei Xu, Yongkui Lu, Wen Xia, Caiwen Du, Dun Xiong, Dong Song, Yanxia Shi, Zhongyu Yuan, Qiufan Zheng, Kuikui Jiang, Xin An, Cong Xue, Jiajia Huang, Xiwen Bi, Meiting Chen, Jingmin Zhang, Shusen Wang, Ruoxi Hong
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) patients are at a high risk of developing metastases in the brain. However, research focusing on treatment strategies for hormonal receptor positive (HR+), HER2+ BC
Externí odkaz:
https://doaj.org/article/074a02d6944e425fbc909d21f71d3bfc
Autor:
Kuikui Jiang, Danyang Zhou, Fei Xu, Wen Xia, Qiufan Zheng, Qianyi Lu, Rongzhen Luo, Ruoxi Hong, Shusen Wang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background We aimed to identify the relationship between the genomic characteristics and clinical outcomes of oligo-metastatic breast cancer. Methods Oligo-metastatic breast cancer diagnosed by pathology from January 2001 and August 2019 wer
Externí odkaz:
https://doaj.org/article/c0a1d2d9d04f4627b9ae8c6f15931385
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Previous studies have shown that high level of TILs in invasive lobular carcinoma (ILC) is associated with poor prognosis, contrary to that in TNBC and HER2‐positive breast cancer. Methods The densities of six immune cell marker
Externí odkaz:
https://doaj.org/article/b2bdd992fc60404ba96b0294912deb47
The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence
Publikováno v:
Annals of Medicine, Vol 55, Iss 1 (2023)
AbstractPurpose To assess the prognostic significance of skin involvement in breast cancer patients with chest wall recurrence (CWR).Methods We retrospectively analyzed the clinicopathological data of breast cancer patients with CWR who were diagnose
Externí odkaz:
https://doaj.org/article/ca632bb76caa4af2b83b9ab5f2e95c85
Autor:
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Meiting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin An
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13019-13030 (2023)
Abstract Background Genetic testing plays an important role in guiding screening, diagnosis, and precision treatment of breast cancer (BC). However, the appropriate genetic testing criteria remain controversial. The current study aims to facilitate t
Externí odkaz:
https://doaj.org/article/fc398c7197174a02b07e752c8b9c66d0
Autor:
Kuikui Jiang, Danyang Zhou, Ruoxi Hong, Qianyi Lu, Fei Xu, Wen Xia, Qiufan Zheng, Shusen Wang
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 2, p 365 (2023)
Background: The Advanced Breast Cancer Alliance conducted a nationwide investigation to understand the current situation of the diagnosis and treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) patient
Externí odkaz:
https://doaj.org/article/69f83511ffa5404e9e48fcf24b41bb93
Publikováno v:
Annals of Medicine, Vol 53, Iss 1, Pp 1358-1369 (2021)
AbstractBackground Triple-negative breast cancer (TNBC) represents about 19% of all breast cancer cases in the Chinese population. Lack of targeted therapy contributes to the poorer outcomes compared with other breast cancer subtypes. Comprehensive g
Externí odkaz:
https://doaj.org/article/7b356f8295064e36ace52c62b6dbb5cb
Autor:
Kaping Lee, Qiufan Zheng, Qianyi Lu, Fei Xu, Ge Qin, Qinglian Zhai, Ruoxi Hong, Miao Chen, Wuguo Deng, Shusen Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/91938223a3324a1aa0055d2145b437aa
Autor:
Danyang Zhou, Kuikui Jiang, Ruoxi Hong, Qianyi Lu, Wen Xia, Mei Li, Chengyou Zheng, Qiufan Zheng, Fei Xu, Shusen Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTo assess the distribution characteristics and the prognostic value of immune infiltration in female oligometastatic breast cancer patients.MethodsWe retrospectively analyzed the clinicopathological data of oligometastatic breast cancer (OM
Externí odkaz:
https://doaj.org/article/b119a69f4d1e42b2808551a5f8a458c1
Autor:
Qiufan Zheng, Shaodong Hong, Yan Huang, Hongyun Zhao, Yunpeng Yang, Xue Hou, Yuanyuan Zhao, Yuxiang Ma, Ting Zhou, Yaxiong Zhang, Wenfeng Fang, Li Zhang
Publikováno v:
Clinical and Translational Medicine, Vol 9, Iss 1, Pp 1-10 (2020)
Abstract Background Despite the impressive anti-tumor activity of osimertinib in epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer (NSCLC) patients, 30–40% of patients still show limited response. There is therefore
Externí odkaz:
https://doaj.org/article/626cab6a74d24c36beaa8eb79a1001b7